Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
271-285 of 4721 results
Mayo Clinic, nference launch startup company for drug development
By PBR Staff Writer
Mayo Clinic and nference have jointly formed a new startup to discover and develop therapies for diseases with unmet medical need using artificial intelligence (AI).
Drug Research > Drug Discovery & Development > News
Biognosys raises new funds to bring Proteomics to life science research market
Proteomics firm Biognosys has secured $5m funding from new and existing investors in an extended series C round.
Drug Research > Drug Discovery & Development > News
Biohaven's BHV-5000 secures FDA orphan drug designation for Rett Syndrome
Biohaven Pharmaceutical’s BHV-5000 has been granted orphan drug designation by the US Food and Drug Administration (FDA) for the treatment for patients with Rett syndrome.
Drug Research > Drug Discovery & Development > News
FDA accepts Tonix’s proposed brand name for TNX-102 SL
Tonix Pharmaceuticals has revealed that the US Food and Drug Administration (FDA) has conditionally accepted the proposed trade name Tonmya for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the management of posttraumatic stress disorder (PTSD).
Drug Research > Drug Discovery & Development > News
Celgene, BeiGene to advance PD-1 inhibitor for solid tumor cancers
By PBR Staff Writer
Celgene has agreed to develop and commercialize BeiGene’s investigational anti-programmed cell death protein 1 (PD-1) inhibitor, BGB-A317 for the treatment of solid tumor cancers.
Drug Research > Drug Discovery & Development > News
GSK enters into drug discovery collaboration with Exscientia
By PBR Staff Writer
British drugmaker GlaxoSmithKline (GSK) has established a drug discovery collaboration with Frontier IP portfolio firm Exscientia.
Drug Research > Drug Discovery & Development > News
CytomX advances CD71-targeting probody drug conjugate into GLP toxicology studies
CytomX Therapeutics has advanced CX-2029, a probody drug conjugate (PDC) targeting CD71 and being developed in collaboration with AbbVie, into GLP toxicology studies, an important step on the path to filing an Investigational New Drug (IND) application next year.
Drug Research > Drug Discovery & Development > News
LifeArc, Dstl & CDRD partner to identify antibacterial drug targets
By PBR Staff Writer
UK-based LifeArc and Defence Science and Technology Laboratory (Dstl) will collaborate with Canada’s The Centre for Drug Research and Development (CDRD) to identify antibacterial drug targets.
Drug Research > Drug Discovery & Development > News
Arix Bioscience buys stake in Mitoconix Bio
Healthcare and life science firm Arix Bioscience has acquired a stake in Mitoconix Bio as part of an oversubscribed $20m Series A financing round.
Drug Research > Drug Discovery & Development > News
FDA accepts for filing Icon’s NDA for Dexycu drug therapy
The US Food and Drug Administration (FDA) has accepted for filing Icon Bioscience (IBI), recently submitted new drug application (NDA) for Dexycu (IBI-10090), a novel drug for treating inflammation associated with cataract surgery.
Drug Research > Drug Discovery & Development > News
Pfizer gets CRL on Epogen biosimilar from FDA
By PBR Staff Writer
The United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Pfizer in connection with its biosimilar candidate to Amgen’s anemia drug Epogen (epoetin alfa).
Drug Research > Drug Discovery & Development > News
Cancer frim Repare Therapeutics announces $68m Series A financing
Repare Therapeutics has secured $68m in a Series A financing round which it will use to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers.
Drug Research > Drug Discovery & Development > News
Rubius Therapeutics raises $120m to advance red blood cell technology
Rubius Therapeutics, which is developing red-cell therapeutics (RCTs) as a new class of medicines to address a range of indications, has raised $120m in a highly oversubscribed private financing.
Drug Research > Drug Discovery & Development > News
EIB supports development of BiondVax’s universal flu vaccine candidate
BiondVax Pharmaceuticals, which is developing a universal vaccine for all strains of influenza, has signed an agreement with the European Investment Bank (EIB) for a €20m loan.
Drug Research > Drug Discovery & Development > News
Axovant’s dementia drug granted FDA fast track designation
Axovant Sciences’ investigational drug nelotanserin has secured fast track designation from the US Food and Drug Administration (FDA) for the treatment of visual hallucinations disorder in dementia with Lewy bodies (DLB).
Drug Research > Drug Discovery & Development > News
271-285 of 4721 results